Vulnerability · CVE-2025-47650
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Infility Infility Global infility-global allows Path Traversal.This issue affects In
Published Aug 20, 2025 · catalog updated Apr 28, 2026 · Infility Global
Last checked Oct 29, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2025-47650. EPSS is 0.43%. Act only if a listed version of Infility Global is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
Same product and reporting
- CVE-2025-68865 · Critical
- CVE-2025-12968 · High
- CVE-2025-52774 · High
- CVE-2025-47651 · High
- Severity
- Medium6.5
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.43%
- Remediation
- Advisory link
- Affected products
- vendor infility Infility Global 0 ≤2.15.06
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Infility Infility Global infility-global allows Path Traversal.This issue affects Infility Global: from n/a through <= 2.15.06.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor infility Infility Global 0 ≤2.15.060 ≤2.15.06
How to fix CVE-2025-47650
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
Seen in 0 ≤2.15.06
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-47650. EPSS is 0.43%. Act only if a listed version of Infility Global is installed.
Which versions are affected?
Compare what you have installed with infility Infility Global 0 ≤2.15.06 0 ≤2.15.06. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.43%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Aug 20, 2025 · EUVD
Detected
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Infility Infility Global infility-global allows Path Traversal.This issue affects Infility Global: from n/a through <= 2.15.06.
Apr 28, 2026 · EUVD
Updated
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Infility Infility Global infility-global allows Path Traversal.This issue affects Infility Global: from n/a through <= 2.15.06.
Sources
- CVE.orgVulnerability recordCVE-2025-47650
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-47650
30-day exploitation probability 0.43%
first.org - EUVDVulnerability recordEUVD-2025-25298
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Infility Infility Global infility-global allows Path Traversal.This issue affects Infility Global: from n/a through <= 2.15.06.
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 23, 2026
- CVE.orgOct 22, 2026
- EUVDOct 21, 2026